X0306 4 2017-04-27 0 0001160308 Savara Inc SVRA 0001283292 RAMSAY DAVID A 6836 BEE CAVE ROAD, BUILDING III SUITE 200 AUSTIN TX 78746 1 0 0 0 Common Stock 2017-04-27 4 M 0 1142 0.00 A 23570 D Common Stock 2019-06-17 4 P 0 10000 2.39 A 33570 D Common Stock 2019-06-17 4 P 0 10000 2.38 A 43570 D Common Stock 2019-06-17 4 P 0 5000 2.37 A 48570 D Common Stock 2019-06-18 4 P 0 5000 2.36 A 53570 D Common Stock 2019-06-18 4 P 0 10215 2.35 A 63785 D Restricted Stock Units 0.00 2017-04-27 4 M 0 1142 0.00 D Common Stock 1142 0 D The vesting of the restricted stock units occurred upon April 27, 2017 upon the consummation of the merger transaction contemplated by the Agreement and Plan of Merger, dated January 6, 2017, by and among Mast Therapeutics, Inc., Savara Inc., and Victoria Merger Corp. (the "Merger Agreement") but due to an administrative error was not reported at that time, and the shares were omitted from subsequent Form 4 filings. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The amount reported reflects the 70-for-one reverse stock split implemented by the issuer on April 27, 2017. The restricted stock units vested in full on April 27, 2017, upon consummation of the merger transaction contemplated by the Merger Agreement. /s/ David Lowrance as attorney-in-fact for David A. Ramsay 2019-06-19